ClinConnect ClinConnect Logo
Search / Trial NCT03489278

Clinical Procedures to Support Research in ALS

Launched by UNIVERSITY OF MIAMI · Apr 4, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The CAPTURE study is a research project aimed at understanding more about amyotrophic lateral sclerosis (ALS) and similar conditions. By looking at information collected from patients' medical records, researchers hope to gain insights that could help improve care and treatment for ALS and related disorders like primary lateral sclerosis and progressive muscular atrophy. This study is currently recruiting participants, and anyone aged 65 to 74 who has been diagnosed with ALS or a related disorder and is receiving care at a specific clinical center may be eligible to join.

To participate, individuals must be able and willing to give their consent, or a designated person can provide consent for them. However, those who cannot understand English or Spanish will not be able to participate. If you join the study, you can expect your medical information to be used in a way that helps researchers learn more about these diseases, potentially benefiting future patients. It's an opportunity to contribute to important research while receiving care at a participating center.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of ALS or a related disorder (e.g. primary lateral sclerosis, progressive muscular atrophy).
  • Receiving care at a clinical center that uses Epic as its EHR.
  • Able and willing to provide informed consent (or informed consent obtainable from a designated proxy).
  • Exclusion Criteria:
  • Inability to understand English and/or Spanish

About University Of Miami

The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.

Locations

New York, New York, United States

Durham, North Carolina, United States

Winston Salem, North Carolina, United States

New York, New York, United States

Minneapolis, Minnesota, United States

Palo Alto, California, United States

Miami, Florida, United States

San Francisco, California, United States

Irvine, California, United States

Kansas City, Kansas, United States

New York City, New York, United States

Portland, Oregon, United States

San Antonio, Texas, United States

Patients applied

0 patients applied

Trial Officials

Michael Benatar, MBChB, MS, DPhil

Principal Investigator

University of Miami

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials